SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001439222-22-000099
Filing Date
2022-11-03
Accepted
2022-11-03 09:46:35
Documents
70
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q agio-20220930.htm   iXBRL 10-Q 1703067
2 EX-10.5 exhibit105-093022.htm EX-10.5 71637
3 EX-31.1 exhibit31-1x09x30x22.htm EX-31.1 9806
4 EX-31.2 exhibit31-2x09x30x22.htm EX-31.2 9817
5 EX-32.1 exhibit32-1x09x30x22.htm EX-32.1 4803
6 EX-32.2 exhibit32-2x09x30x22.htm EX-32.2 4798
  Complete submission text file 0001439222-22-000099.txt   6802675

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agio-20220930.xsd EX-101.SCH 40343
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agio-20220930_cal.xml EX-101.CAL 81463
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agio-20220930_def.xml EX-101.DEF 166646
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agio-20220930_lab.xml EX-101.LAB 530533
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agio-20220930_pre.xml EX-101.PRE 350244
64 EXTRACTED XBRL INSTANCE DOCUMENT agio-20220930_htm.xml XML 1095471
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 221356637
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences